Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 32% ± 17% | |
peripheral blood | 11 studies | 22% ± 8% | |
lung | 9 studies | 25% ± 8% | |
eye | 8 studies | 24% ± 7% | |
bone marrow | 4 studies | 20% ± 4% | |
heart | 4 studies | 22% ± 5% | |
adipose | 4 studies | 25% ± 7% | |
intestine | 3 studies | 24% ± 9% | |
lymph node | 3 studies | 20% ± 5% | |
liver | 3 studies | 34% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 5590.19 | 21 / 21 | 100% | 41.01 | 504 / 504 |
esophagus | 100% | 5232.54 | 1445 / 1445 | 100% | 41.37 | 183 / 183 |
ovary | 100% | 7172.47 | 180 / 180 | 100% | 43.81 | 430 / 430 |
breast | 100% | 6200.94 | 459 / 459 | 100% | 59.54 | 1117 / 1118 |
prostate | 100% | 5864.38 | 245 / 245 | 100% | 47.17 | 501 / 502 |
lung | 100% | 6132.96 | 578 / 578 | 100% | 39.53 | 1152 / 1155 |
thymus | 100% | 7192.54 | 653 / 653 | 100% | 55.60 | 602 / 605 |
kidney | 100% | 4996.40 | 89 / 89 | 99% | 41.26 | 896 / 901 |
brain | 99% | 3897.18 | 2626 / 2642 | 100% | 54.67 | 705 / 705 |
uterus | 100% | 7197.06 | 170 / 170 | 99% | 42.94 | 455 / 459 |
stomach | 100% | 4328.69 | 359 / 359 | 99% | 38.30 | 283 / 286 |
pancreas | 100% | 2979.44 | 327 / 328 | 99% | 40.29 | 176 / 178 |
intestine | 100% | 6434.55 | 966 / 966 | 98% | 36.01 | 519 / 527 |
adrenal gland | 100% | 4615.29 | 258 / 258 | 98% | 32.28 | 226 / 230 |
skin | 100% | 5100.29 | 1807 / 1809 | 98% | 56.88 | 464 / 472 |
liver | 100% | 3296.76 | 226 / 226 | 97% | 23.68 | 395 / 406 |
adipose | 100% | 6701.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6694.24 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 52.54 | 29 / 29 |
spleen | 100% | 7179.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 39.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.11 | 1 / 1 |
muscle | 100% | 3583.66 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 3559.11 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 4303.91 | 899 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 83% | 17.67 | 66 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010468 | Biological process | regulation of gene expression |
GO_0040029 | Biological process | epigenetic regulation of gene expression |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CGGBP1 |
Protein name | CGG triplet repeat binding protein 1 CGG triplet repeat-binding protein 1 (CGG-binding protein 1) (20 kDa CGG-binding protein) (p20-CGGBP DNA-binding protein) |
Synonyms | CGGBP |
Description | FUNCTION: Binds to nonmethylated 5'-d(CGG)(n)-3' trinucleotide repeats in the FMR1 promoter. May play a role in regulating FMR1 promoter. . |
Accessions | C9JUJ0 ENST00000675130.1 Q9UFW8 ENST00000462901.5 ENST00000309534.10 ENST00000467332.1 ENST00000482016.6 ENST00000398392.2 |